Cell Genesys, Inc. (CEGE)

upanddown100 (< 20) Submitted: 2/16/07 12:21 PM : Start Price: $3.49 CEGE Score: -17.76

The stock price is disproportionally weighed down by it's debt. With money so cheap, CEGE has plenty of cash that it would prefer to put to work rather than to pay down debt. And it is putting it to work on cures for major killers- prostate cancer an...

Report this Post Replies: 2 | Reply | Permalink

NetscribeHealthC (33.66) Submitted: 3/08/07 7:25 AM : Start Price: $3.02 CEGE Score: -10.07

Cell Genesys engages in the development and commercialization of novel biological therapies for patients suffering with cancer. The company is developing cell-based immunotherapies and oncolytic virus therapies to treat different types of cancer. Its...

Report this Post Replies: 0 | Reply | Permalink

2tal (23.74) Submitted: 4/10/07 1:52 PM : Start Price: $6.25 CEGE Score: -48.74

Another small biotech I jumped in and watched it fall but now it is starting to run. Their work is paying off and the stock price will reflect that. Maybe it is time to buy my second third?!

Report this Post Replies: 0 | Reply | Permalink

Babsly (56.08) Submitted: 12/03/07 4:41 PM : Start Price: $2.26 CEGE Score: 20.51

Cell Genisis is due to report information on their outstanding GVAX prostate cancer vaccine trials that are in stage III and II. The results are pitched as being positive by the knowledgeable few, and if you don't get in before the hype, you've misse...

Report this Post Replies: 0 | Reply | Permalink

ctmedic00 (99.94) Submitted: 1/26/07 1:09 PM : Start Price: $3.23 CEGE Score: -13.68

I heard one of their subsidaries CEOs giving an interview and was very interested in hearing about the DNA sequencing and the value that is returning. If he is correct and, I don't know either way, this is a great speculative bet. Anything involvin...

Report this Post Replies: 1 | Reply | Permalink

cardinals18 (52.86) Submitted: 3/24/08 11:25 AM : Start Price: $2.38 CEGE Score: 7.63

Will get a partner deal done soon, also expect great news comming out of trials.

Report this Post Replies: 0 | Reply | Permalink

drummerboy1985 (71.58) Submitted: 2/20/08 12:52 PM : Start Price: $2.90 CEGE Score: -10.31

This stock is big because of a drug that has been shown to help prostate cancer patients to live longer. Everyone knows that it's a really big deal right now in this country. Below is what an analyst thinks about this stock. I'm calling higher.

"...

Report this Post Replies: 0 | Reply | Permalink

SavvyPicker (< 20) Submitted: 4/09/07 5:13 PM : Start Price: $7.09 CEGE Score: 53.52

This stock has much to prove in the months (and months) ahead. More specifically, its questionable Phase II results are well documented, along with the onset of more promising competition. Unfortunately, in the wake of disastrous results, investors r...

Report this Post Replies: 0 | Reply | Permalink

obenation (21.39) Submitted: 4/30/07 7:15 PM : Start Price: $4.36 CEGE Score: -29.83

this is a short term momentum play assuming DNDN is approved

Report this Post Replies: 0 | Reply | Permalink

mamicro (98.61) Submitted: 10/17/07 3:54 PM : Start Price: $3.63 CEGE Score: 15.63

It needs some good news to break out. The trials are't far enough along.

Report this Post Replies: 0 | Reply | Permalink